USANA Health Sciences (USNA) News Today

USANA Health Sciences (NYSE:USNA) Shares Up 4.3% After Better-Than-Expected Earnings

USANA Health Sciences (NYSE:USNA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same period last year, the firm posted $0.59 earnings per share.

DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating on the stock in a research report on Wednesday.

USANA Health Sciences (NYSE:USNA) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.450-2.450 for the period, compared to the consensus estimate of 2.500. The company also issued revenue guidance of $850.0 millionillion-$850.0 millionillion, compared to the consensus estimate of $861.9 millionillion.

USANA Health Sciences (NYSE:USNA) Reaches New 52-Week Low - Here's Why

Unison Advisors LLC acquired a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 18,000 shares of the company's stock, valued at approximately $683,000. Unison Advisors L

USANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low - Should You Sell?

USANA Health Sciences (NYSE:USNA) Hits New 1-Year Low at $35.63

Deerfield Management Company L.P. Series C boosted its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 297.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned

American Century Companies Inc. lifted its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 12.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 159,782 shares of the company's stock after buying an ad

Pacer Advisors Inc. boosted its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 467,352 shares of the company's stock after purchasin

Renaissance Technologies LLC trimmed its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 3.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,179,163 shares of the company's stock after sell

WINTON GROUP Ltd bought a new position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 19,663 shares of the company's stock, valued at approximately $890,

USANA Health Sciences (NYSE:USNA) Reaches New 52-Week Low at $37.05

Pzena Investment Management LLC increased its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 24.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 976,633 shares of the company's stock after buy

Panagora Asset Management Inc. boosted its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 143.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,881 shares of the co

Assenagon Asset Management S.A. grew its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 32.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 109,252 shares of the company's stock after purchas

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) insider Paul A. Jones sold 6,266 shares of the company's stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

USANA Health Sciences (NYSE:USNA) Hits New 12-Month Low at $38.56

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Gilbert A. Fuller sold 674 shares of the firm's stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

USANA Health Sciences (NYSE:USNA) Hits New 12-Month Low at $39.78

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Analysts at DA Davidson issued their Q3 2024 earnings per share estimates for shares of USANA Health Sciences in a research report issued on Thursday, July 25th. DA Davidson analyst L. Weiser expects that the company will earn $0.46 per shar

DA Davidson decreased their price target on USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating on the stock in a report on Thursday.

Acadian Asset Management LLC reduced its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 56.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,974 shares of the company's stock after selling 50,818